Literature DB >> 7132952

Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.

V Maes, Y Engelborghs, J Hoebeke, Y Maras, A Vercruysse.   

Abstract

Binding of warfarin to human serum albumin results in a red shift of the UV absorption maximum, suggesting that the binding site is a hydrophobic area of the protein. The enhancement of the fluorescence of warfarin upon binding to human serum albumin was used to study the binding equilibrium and the kinetics of this drug-protein interaction. From equilibrium fluorescence measurements, contributions from free and bound warfarin could be evaluated. From the resulting Scatchard plots, equilibrium constants ranging from 4.2 X 10(5) to 3.5 X 10(5) M-1 for temperatures from 8 degrees to 37 degrees were calculated. The reaction is slightly exothermic (delta H = -1.2 kcal m mole-1) and strongly entropy-driven (delta S = +21 cal . mole-1 . K-1). The reaction rate constants of the warfarin-albumin interaction were determined by the stopped-flow technique. The association rate constant varies from 2.2 X 10(5) to 7.7 X 10(5) M-1 sec-1 from 10 degrees to 32 degrees. The corresponding activation enthalpy is 9.0 kcal . mole-1. These values are not consistent with a diffusion-controlled reaction. The dissociation of the complex was studied by making use of the direct competition between warfarin and phenylbutazone for the same binding site. The dissociation rate constant varies from 2.5 to 10.8 sec-1 in the same temperature range. Activation parameters obtained in the kinetic experiments correspond very well with the thermodynamic parameters calculated from the equilibrium study, validating the fluorescence approach to the equilibrium studies.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7132952

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  12 in total

1.  Conformational stability and warfarin-binding properties of human serum albumin studied by recombinant mutants.

Authors:  H Watanabe; U Kragh-Hansen; S Tanase; K Nakajou; M Mitarai; Y Iwao; T Maruyama; M Otagiri
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

2.  Kinetic analysis of albumin-mediated uptake of warfarin by perfused rat liver.

Authors:  S C Tsao; Y Sugiyama; Y Sawada; T Iga; M Hanano
Journal:  J Pharmacokinet Biopharm       Date:  1988-04

3.  Relations between high-affinity binding sites of markers for binding regions on human serum albumin.

Authors:  U Kragh-Hansen
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

4.  Isoniazid and rifampicin inhibit allosterically heme binding to albumin and peroxynitrite isomerization by heme-albumin.

Authors:  Paolo Ascenzi; Alessandro Bolli; Alessandra di Masi; Grazia R Tundo; Gabriella Fanali; Massimo Coletta; Mauro Fasano
Journal:  J Biol Inorg Chem       Date:  2010-09-25       Impact factor: 3.358

5.  Five recombinant fragments of human serum albumin-tools for the characterization of the warfarin binding site.

Authors:  M Dockal; M Chang; D C Carter; F Rüker
Journal:  Protein Sci       Date:  2000-08       Impact factor: 6.725

Review 6.  Analytical methods for kinetic studies of biological interactions: A review.

Authors:  Xiwei Zheng; Cong Bi; Zhao Li; Maria Podariu; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2015-01-27       Impact factor: 3.935

7.  Thermodynamics, conformation and active sites of the binding of Zn-Nd hetero-bimetallic Schiff base to bovine serum albumin.

Authors:  Qi Xiao; Shan Huang; Yi Liu; Fang-fang Tian; Jun-cheng Zhu
Journal:  J Fluoresc       Date:  2008-10-21       Impact factor: 2.217

8.  Noncompetitive peak decay analysis of drug-protein dissociation by high-performance affinity chromatography.

Authors:  Jianzhong Chen; John E Schiel; David S Hage
Journal:  J Sep Sci       Date:  2009-05       Impact factor: 3.645

9.  Interactive multiple binding of oleic acid, warfarin and ibuprofen with human serum albumin revealed by thermal and fluorescence studies.

Authors:  Rita Guzzi; Rosa Bartucci
Journal:  Eur Biophys J       Date:  2022-01-20       Impact factor: 1.733

10.  Development and characterization of a novel fusion protein of a mutated granulocyte colony-stimulating factor and human serum albumin in Pichia pastoris.

Authors:  Yan-Shan Huang; Xiao-Fang Wen; Zhi-Yu Yang; Yi-Liang Wu; You Lu; Lin-Fu Zhou
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.